Clinical Trial

TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-07
notable Primary completion pushed: 2026-06-12 -> 2026-09-12 2026-07-07
minor Completion pushed: 2026-06-12 -> 2026-09-12 2026-07-07
Trial Details
NCT Number NCT03737604
Lead Sponsor University of California, Davis
Conditions Transplant;Failure,Kidney, Pain, Postoperative
Enrollment 200 participants
Start Date 2018-10-04
Primary Completion 2026-09-12 (estimated)
Study Completion 2026-09-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-06